ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
03 Oct 2023

Acarix publishes prospectus in connection with the company’s fully guaranteed rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Oct 2023

Acarix offentliggör prospekt i samband med bolagets fullt garanterade företrädesemission

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HONGKONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
22 Dec 2022

Acarix publish supplement to prospectus

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
22 Dec 2022

Acarix offentliggör tilläggsprospekt

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AU...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Dec 2022

Acarix publishes prospectus in connection with the company’s rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Dec 2022

Acarix offentliggör prospekt i samband med bolagets företrädesemission

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AU...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Nov 2021

Acarix offentliggör prospekt i samband med företrädesemission om cirka 79 MSEK

Acarix offentliggör prospekt i samband med företrädesemission om cirka 79 MSEK Extra bolagsstämman i Acarix AB ("Acarix" ell...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Nov 2021

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million The Extraordinary General Meeting of Acari...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Sep 2020

Acarix publishes a supplement to the prospectus

  Press releaseMalmö, Sweden September 3, 2020 Acarix publishes a supplement to the prospectus The board of directors of Acarix AB (...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Aug 2020

Acarix publishes prospectus in connection with rights issue of approximately SEK 56 million

Acarix publishes prospectus in connection with rights issue of approximately SEK 56 million The Extraordinary General Meeting o...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Aug 2020

Acarix offentliggör prospekt i samband med företrädesemission om cirka 56 MSEK

Acarix offentliggör prospekt  i samband med företrädesemission om cirka 56 MSEK Extra bolagsstämma i Acarix AB ("Acarix" ell...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Sep 2019

Acarix publish EU growth prospectus in connection with rights issue of up to approximately SEK 51.8 million

Press release Malmö, 30 September 2019 Acarix publish EU growth prospectus in connection with rights issue of up to approximately SEK...
Continue reading
  • 1
  • 2
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.